Dr. Francine Garrett-Bakelman, an Instructor in Medicine in the Division of Hematology and Medical Oncology, was invited by NASA to speak on "Medical Genomics." On February 11, 2016, she delivered a talk at the Universities Space Research Association, Lunar and Planetary Institute, in Houston, Texas, reporting on medical genomic technologies, applications, and their integration into clinical care.
Dr. Lewis C. Cantley has been awarded the prestigious 2016 Wolf Prize in Medicine. Dr. Cantley, who serves as the Meyer Director of the Sandra and Edward Meyer Cancer Center, received this award in recognition of his groundbreaking discovery of the enzyme (PI3K) and the signaling pathway that it controls. Dr. Cantley found that human cancers frequently occur due to activation of PI3K, which has led to targeted drug development and clinical trials in the field of cancer.
The Mayo Clinic has received an $11 million grant from the National Cancer Institute to support research addressing current and long-term unmet healthcare needs of people with non-Hodgkin lymphoma (NHL). The is a collaborative effort among multiple institutions.
This award is presented annually to members of the Weill Department of Medicine below the rank of professor who perform on outstanding levels in the areas of clinical and/or basic biomedical research. It is supported by the Michael Wolk Foundation.
Initiated in 2002, the Fellow Award in Research is presented annually to fellows within the Weill Department of Medicine who have presented outstanding research. This year's finalists were announced at the June 10 Medicine Grand Rounds (13th Annual).
Dr. Faltas is currently focused on molecular profiling of metastatic platinum-resistant urothelial bladder carcinoma, a disease with no approved therapies. In particular, he is investigating the molecular changes that occur as urothelial cancer evolves under the effect of chemotherapy and metastatic spread. Identifying these molecular changes will hopefully lead to finding "druggable" targets for translation into therapeutic clinical trials.
As a featured speaker at the AMEC conference, entitled "Unsilencing the Unheard and the Underserved," Dr. Garrett-Bakelman addressed vital issues concerning SNMA member's education and health disparities. Topics covered included potential paths to be taken to become a physician-scientist; career options post graduate training; and approaches to work-life balance.
Dr. Andrew I. Schafer gave the Keynote Address at the spring meeting of the Royal College of Physicians in London on Feb. 27, 2015, to an audience that included HRH Princess Anne. In his address, Dr. Schafer talked about the future of academic medicine, comparing and contrasting the situations in the U.S. and the United Kingdom and Europe, in areas such as medical education and research funding. Following the lecture, the Academy of Medical Sciences of England sponsored a series of brief...
Membership to the AAP is a coveted honor and reflects remarkable dedication to the advancement of scientific and practical medicine. Founded in 1885 as a non-profit professional organization, the AAP has some 1,300 active members and 600 honorary members.
Dr. Richard T. Silver has dedicated his efforts for many decades to finding a cure for Myeloproliferative Neoplasms (MPNs) and chronic myeloid leukemia, while bringing the best in patient care and scientific advancement to the clinical setting. MPNs are a group of diseases related to the excessive production of bone marrow cells.
